Early Bevacizumab Treatment of Central Retinal Vein Occlusion

American Journal of Ophthalmology

Volumn 144, Issue 6, 2007, Pages 864-871

  Ferrara, Daniela C ^a   Koizumi, Hideki ^a   Spaide, Richard F ^a  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; OPTIC NERVE; PAPILLEDEMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VEIN DIAMETER; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INJECTIONS; MALE; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 36248981014     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.07.038     Document Type: Article

References (25)

1. Green W.R., Chan C.C., Hutchins G.M., and Terry J.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 79 (1981) 371-422
2. Hayreh S.S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24 (2005) 493-519
3. The Central Vein Occlusion Study Group M Report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 102 (1995) 1425-1433
4. Gregori N.Z., Rosenfeld P.J., Puliafito C.A., et al. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Retina 26 (2006) 889-895
5. Goff M.J., Jumper J.M., Yang S.S., et al. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Retina 26 (2006) 896-901
6. Patel P.J., Zaheer I., and Karia N. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Eye (2007) Forthcoming
7. Ramezani A., Entezari M., Moradian S., Tabatabaei H., and Kadkhodaei S. Intravitreal triamcinolone for acute central retinal vein occlusion: a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 244 (2006) 1601-1606
8. Moschos M.M., Brouzas D., Loukianou E., Apostolopoulos M., and Moschos M. Intraocular triamcinolone acetonide for macular edema due to CRVO: a multifocal-ERG and OCT study. Doc Ophthalmol 114 (2007) 1-7
9. Rosenfeld P.J., Fung A.E., and Puliafito C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36 (2005) 336-339
10. Iturralde D., Spaide R.F., Meyerle C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26 (2006) 279-284
11. Costa R.A., Jorge R., Calucci D., Melo L.A., Cardillo J.A., and Scott I.U. Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 27 (2007) 141-149
12. Hart W.E., Goldbaum M., Cote B., Kube P., and Nelson M.R. Measurement and classification of retinal vascular tortuosity. Int J Med Inform 53 (1999) 239-252
13. Vogel S. Comparative biomechanics (2003), Princeton University Press, Princeton, New Jersey 210-214
14. Johnson L.N., Krohel G.B., Madsen R.W., and March Jr. G.A. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105 (1998) 2313-2317
15. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 (1997) 486-491
16. The Central Vein Occlusion Study Group N report. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 102 (1995) 1434-1444
17. Hayreh S.S. The CVOS Group M and N reports. Ophthalmology 103 (1996) 350-352
18. Takahashi K., Muraoka K., Kishi S., and Shimizu K. Formation of retinochoroidal collaterals in central retinal vein occlusion. Am J Ophthalmol 126 (1998) 91-99
19. Garciia-Arumii J., Boixadera A., Martinez-Castillo V., et al. Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol 121 (2003) 1385-1391
20. Spaide R.F., Klancnik Jr. J.M., and Gross N.E. Retinal choroidal collateral circulation after radial optic neurotomy correlated with the lessening of macular edema. Retina 24 (2004) 356-359
21. Koizumi K., Nishiura M., Yamamoto T., et al. Intentional complete interruption of a retinal vein after vitrectomy might improve the rate of successful chorioretinal venous anastomosis formation in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240 (2002) 787-794
22. Tolentino M.J., Miller J.W., Gragoudas E.S., et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103 (1996) 1820-1828
23. Tolentino M.J., McLeod D.S., Taomoto M., Otsuji T., Adamis A.P., and Lutty G.A. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol 133 (2002) 373-385
24. Pe'er J., Folberg R., Itin A., Gnessin H., Hemo I., and Keshet E. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105 (1998) 412-416
25. Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 (1994) 1480-1487